反应详情

The title compound was prepared analogously to Example A(97) where 6-Chloro-[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde was substituted in place of 2-ethyl-4-methyl-1H-imidazole-5-carbaldehyde and 1-{4-[2-(2-Cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl)-ethyl]-2-fluoro-phenyl}-cyclopentanecarbonitrile (Example A(189) (was substituted in place of 2-{4-[2-(2-cyclopentyl-4-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl]-2-fluorophenyl}-2-methylpropanenitrile. 1H NMR (400 MHz, CDCl3) δ: 1.41–1.98 (m, 17 H), 2.30–2.68 (m, 6 H), 3.62 (d, J=16 Hz, 1 H), 3.71 (d, J=16 Hz, 1 H), 6.99–7.03 (m, 2 H), 7.21–7.25 (m, 1 H), 8.74 (s, 1 H), 9.45 (s, 1 H), 10.8 (s, 1 H). Anal. Calcd. For C30H31ClFN5O3: C, 63.88; H, 5.54; N, 12.42. Found: C, 63.73; H, 5.71; N, 12.17. MS (ESI): 564 (M+H)+.